MEDICLIN Aktiengesellschaft (FRA:MED)
Germany · Delayed Price · Currency is EUR 4.020
+0.020 (0.50%)
At close: Jan 30, 2026
FRA:MED Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 777.46 | 748.75 | 730.07 | 704.7 | 673.14 | 659.86 |
Other Revenue | 16.45 | 12.9 | 31.53 | 13.89 | 10.65 | 1.94 |
| 793.91 | 761.65 | 761.6 | 718.58 | 683.79 | 661.81 | |
Revenue Growth (YoY) | 3.65% | 0.01% | 5.99% | 5.09% | 3.32% | -2.67% |
Cost of Revenue | 610.31 | 596.69 | 599.38 | 587.75 | 561.6 | 551.52 |
Gross Profit | 183.6 | 164.96 | 162.21 | 130.84 | 122.19 | 110.29 |
Selling, General & Admin | 4.9 | 4.9 | 4.3 | 5.6 | 3.5 | 3.2 |
Other Operating Expenses | 61.8 | 59.52 | 63.93 | 36.9 | 35.62 | 30.64 |
Operating Expenses | 118.9 | 114.7 | 120.51 | 120.5 | 119.36 | 119.59 |
Operating Income | 64.7 | 50.26 | 41.7 | 10.34 | 2.83 | -9.3 |
Interest Expense | -20.96 | -22.4 | -22.3 | -10.08 | -9.06 | -9.78 |
Interest & Investment Income | 1.79 | 2.62 | 2.54 | 0.88 | 0.05 | 0.05 |
Earnings From Equity Investments | 0.12 | - | - | - | 0.16 | 0.05 |
Other Non Operating Income (Expenses) | 1.41 | 1.41 | 3.05 | 1.8 | 1.8 | 1.7 |
EBT Excluding Unusual Items | 47.06 | 31.89 | 24.99 | 2.94 | -4.22 | -17.28 |
Impairment of Goodwill | - | - | -33.13 | - | -0.02 | - |
Gain (Loss) on Sale of Assets | 0.23 | 0.23 | 0.05 | 0.24 | 0.09 | -1.21 |
Asset Writedown | - | - | -0.6 | - | - | - |
Other Unusual Items | - | - | - | 6.6 | 6.6 | 8.4 |
Pretax Income | 47.29 | 32.12 | -8.69 | 9.78 | 2.45 | -10.09 |
Income Tax Expense | 12.01 | 7.21 | 2.04 | 0.06 | 0.96 | -1.05 |
Earnings From Continuing Operations | 35.28 | 24.91 | -10.72 | 9.72 | 1.49 | -9.03 |
Minority Interest in Earnings | -0.23 | -0.07 | -0.05 | -0.28 | -0.02 | 0.04 |
Net Income | 35.05 | 24.84 | -10.78 | 9.44 | 1.46 | -9 |
Net Income to Common | 35.05 | 24.84 | -10.78 | 9.44 | 1.46 | -9 |
Net Income Growth | - | - | - | 545.98% | - | - |
Shares Outstanding (Basic) | 48 | 48 | 48 | 48 | 48 | 48 |
Shares Outstanding (Diluted) | 48 | 48 | 48 | 48 | 48 | 48 |
EPS (Basic) | 0.74 | 0.52 | -0.23 | 0.20 | 0.03 | -0.19 |
EPS (Diluted) | 0.74 | 0.52 | -0.23 | 0.20 | 0.03 | -0.19 |
EPS Growth | - | - | - | 562.50% | - | - |
Free Cash Flow | 52.47 | 42.52 | 43.58 | 10.27 | 66.74 | 96.44 |
Free Cash Flow Per Share | 1.10 | 0.90 | 0.92 | 0.22 | 1.41 | 2.03 |
Dividend Per Share | 0.040 | 0.040 | - | - | - | - |
Gross Margin | 23.13% | 21.66% | 21.30% | 18.21% | 17.87% | 16.66% |
Operating Margin | 8.15% | 6.60% | 5.48% | 1.44% | 0.41% | -1.41% |
Profit Margin | 4.42% | 3.26% | -1.42% | 1.31% | 0.21% | -1.36% |
Free Cash Flow Margin | 6.61% | 5.58% | 5.72% | 1.43% | 9.76% | 14.57% |
EBITDA | 88.05 | 71.69 | 66.6 | 36.93 | 29.24 | 20.63 |
EBITDA Margin | 11.09% | 9.41% | 8.74% | 5.14% | 4.28% | 3.12% |
D&A For EBITDA | 23.35 | 21.43 | 24.9 | 26.59 | 26.41 | 29.93 |
EBIT | 64.7 | 50.26 | 41.7 | 10.34 | 2.83 | -9.3 |
EBIT Margin | 8.15% | 6.60% | 5.48% | 1.44% | 0.41% | -1.41% |
Effective Tax Rate | 25.40% | 22.44% | - | 0.59% | 39.28% | - |
Revenue as Reported | 797.34 | 765.08 | 766.75 | 722.32 | 687.08 | 670.99 |
Advertising Expenses | - | - | - | 2.2 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.